Contineum Therapeutics Inc. - Ordinary Shares - Class A
XNAS: CTNM
Contineum Therapeutics Inc. - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart
about
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIP...
Read More
6.01
0.81
(15.58%)
300.1K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Contineum Therapeutics Inc... Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..